Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

The SLC1 high-affinity glutamate and neutral amino acid transporter family.

Kanai Y, Clémençon B, Simonin A, Leuenberger M, Lochner M, Weisstanner M, Hediger MA.

Mol Aspects Med. 2013 Apr-Jun;34(2-3):108-20. doi: 10.1016/j.mam.2013.01.001. Review.

PMID:
23506861
2.

The glutamate/neutral amino acid transporter family SLC1: molecular, physiological and pharmacological aspects.

Kanai Y, Hediger MA.

Pflugers Arch. 2004 Feb;447(5):469-79. Epub 2003 Oct 7. Review.

PMID:
14530974
3.

The glutamate and neutral amino acid transporter family: physiological and pharmacological implications.

Kanai Y, Hediger MA.

Eur J Pharmacol. 2003 Oct 31;479(1-3):237-47. Review.

PMID:
14612154
4.

Molecular determinants for functional differences between alanine-serine-cysteine transporter 1 and other glutamate transporter family members.

Scopelliti AJ, Ryan RM, Vandenberg RJ.

J Biol Chem. 2013 Mar 22;288(12):8250-7. doi: 10.1074/jbc.M112.441022. Epub 2013 Feb 7.

5.

High-affinity glutamate transporter GLAST/EAAT1 regulates cell surface expression of glutamine/neutral amino acid transporter ASCT2 in human fetal astrocytes.

Gegelashvili M, Rodriguez-Kern A, Pirozhkova I, Zhang J, Sung L, Gegelashvili G.

Neurochem Int. 2006 May-Jun;48(6-7):611-5. Epub 2006 Mar 3.

PMID:
16516348
6.

Characterization of novel L-threo-beta-benzyloxyaspartate derivatives, potent blockers of the glutamate transporters.

Shimamoto K, Sakai R, Takaoka K, Yumoto N, Nakajima T, Amara SG, Shigeri Y.

Mol Pharmacol. 2004 Apr;65(4):1008-15.

7.

Inhibitory effects of (2S, 3S)-3-[3-[4-(trifluoromethyl)benzoylamino]benzyloxy]aspartate (TFB-TBOA) on the astrocytic sodium responses to glutamate.

Bozzo L, Chatton JY.

Brain Res. 2010 Feb 26;1316:27-34. doi: 10.1016/j.brainres.2009.12.028. Epub 2009 Dec 22.

PMID:
20026319
8.
9.

Transport of L-[14C]cystine and L-[14C]cysteine by subtypes of high affinity glutamate transporters over-expressed in HEK cells.

Hayes D, Wiessner M, Rauen T, McBean GJ.

Neurochem Int. 2005 Jun;46(8):585-94. Epub 2005 Apr 12.

PMID:
15863236
10.

Effects of threo-beta-hydroxyaspartate derivatives on excitatory amino acid transporters (EAAT4 and EAAT5).

Shigeri Y, Shimamoto K, Yasuda-Kamatani Y, Seal RP, Yumoto N, Nakajima T, Amara SG.

J Neurochem. 2001 Oct;79(2):297-302.

11.

SLC1 glutamate transporters and diseases: psychiatric diseases and pathological pain.

Nakagawa T, Kaneko S.

Curr Mol Pharmacol. 2013 Jul;6(2):66-73. Review.

PMID:
23876150
12.

Cloning and functional characterization of a system ASC-like Na+-dependent neutral amino acid transporter.

Utsunomiya-Tate N, Endou H, Kanai Y.

J Biol Chem. 1996 Jun 21;271(25):14883-90.

13.

Structural selectivity and molecular nature of L-glutamate transport in cultured human fibroblasts.

Cooper B, Chebib M, Shen J, King NJ, Darvey IG, Kuchel PW, Rothstein JD, Balcar VJ.

Arch Biochem Biophys. 1998 May 15;353(2):356-64.

PMID:
9606970
14.

Characterization of the tritium-labeled analog of L-threo-beta-benzyloxyaspartate binding to glutamate transporters.

Shimamoto K, Otsubo Y, Shigeri Y, Yasuda-Kamatani Y, Satoh M, Kaneko S, Nakagawa T.

Mol Pharmacol. 2007 Jan;71(1):294-302. Epub 2006 Oct 17.

15.

DL-threo-beta-benzyloxyaspartate, a potent blocker of excitatory amino acid transporters.

Shimamoto K, Lebrun B, Yasuda-Kamatani Y, Sakaitani M, Shigeri Y, Yumoto N, Nakajima T.

Mol Pharmacol. 1998 Feb;53(2):195-201.

16.

Differential modulation of the glutamate transporters GLT1, GLAST and EAAC1 by docosahexaenoic acid.

Berry CB, Hayes D, Murphy A, Wiessner M, Rauen T, McBean GJ.

Brain Res. 2005 Mar 10;1037(1-2):123-33.

PMID:
15777760
17.

Molecular pharmacology of glutamate transporters, EAATs and VGLUTs.

Shigeri Y, Seal RP, Shimamoto K.

Brain Res Brain Res Rev. 2004 Jul;45(3):250-65. Review.

PMID:
15210307
18.
19.

GABA and Glutamate Transporters in Brain.

Zhou Y, Danbolt NC.

Front Endocrinol (Lausanne). 2013 Nov 11;4:165. doi: 10.3389/fendo.2013.00165. eCollection 2013. Review.

20.

D-Serine Is a Substrate for Neutral Amino Acid Transporters ASCT1/SLC1A4 and ASCT2/SLC1A5, and Is Transported by Both Subtypes in Rat Hippocampal Astrocyte Cultures.

Foster AC, Farnsworth J, Lind GE, Li YX, Yang JY, Dang V, Penjwini M, Viswanath V, Staubli U, Kavanaugh MP.

PLoS One. 2016 Jun 7;11(6):e0156551. doi: 10.1371/journal.pone.0156551. eCollection 2016.

Items per page

Supplemental Content

Write to the Help Desk